On Sept. 15, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 14, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 13, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 10, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 9, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
FDA is “asking for the assistance of the import community” to help stop the importation of animal ivermectin for use in the treatment of COVID-19 in humans, according to a CSMS message posted by CBP. “Recent news stories and a Health Alert published by the U.S. Centers for Disease Control and Prevention note that poison control centers across the United States are seeing a sharp spike in reports of people suffering adverse health effects after taking ivermectin intended for animals,” FDA said. “We are asking you to help us educate importers and consumers regarding the health consequences of using animal ivermectin, and to report any suspicious attempt to import Ivermectin/Stromectol to FDA-COVID-19-Fraudulent-Products@fda.hhs.gov.”
FDA has issued its Enforcement Report for Sept. 8, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.
On Sept. 8, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 7 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 3, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of: